Serum Institute of India (SII) | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
June 15, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JUNE 15, 2025

Serum Institute of India (SII)

FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Novavax vaccine efficacy data promising; trials in advanced stage: Indian govt

On Monday, Novavax Inc said its vaccine was 90% effective at preventing symptomatic Covid-19 and 100% effective at preventing moderate and severe symptoms of the virus

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Novavax Covid vaccine to be made by Serum Institute, shows 90% efficacy

Vials of Russia's Sputnik V COVID-19 vaccine seen at an airport in Republic of San Marino. (REUTERS)
Coronavirus chronicle

Serum India gets DCGI’s nod to manufacture Sputnik V

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas
Coronavirus chronicle

Vaccine maker Serum seeks indemnity protection in India

A medical worker holds a box of Sputnik V vaccine against the coronavirus disease (Covid-19) in Moscow. Photo : Reuters
Coronavirus chronicle

Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V

A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters
Coronavirus chronicle

India's Serum Institute to raise AstraZeneca Covid-19 vaccine output in June

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
South Asia

Poonawalla is the only official spokesperson, SII says after executive criticises Indian govt

FILE PHOTO: A policeman asks people who came to receive a dose of a coronavirus vaccine to leave as they stand outside the gate of a vaccination centre which was closed due to unavailability of the supply of COVID-19 vaccine, in Mumbai, India. REUTERS/Francis Mascarenhas/File Photo
Coronavirus chronicle

India's vaccine output likely to fall short of target, sources say

Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. REUTERS/Francis Mascarenhas
Coronavirus chronicle

Poonawalla defends vaccine export, says ‘daily cases were at an all-time low’

Adar PoonawallaPhotographer: Dhiraj Singh/Bloomberg
South Asia

'Never exported vaccines at cost of people in India': SII CEO Poonawalla

Employees operate a filling machine inside a lab at the Serum Institute of India, in Pune, India, November 30, 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/Files
Coronavirus chronicle

India's Serum Institute to start export of Covid-19 vaccine by year-end

Finance Minister AHM Mustafa Kamal. Photo Collected
Covid-19 in Bangladesh

Bangladesh will be refunded if Serum fails to provide vaccines: Finance Minister

The Serum Institute was founded by Adar Poonawalla's father Cyrus Poonawalla in 1966 Photo: Reuters
Coronavirus chronicle

Vaccine prince exposes India’s best and worst

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net